HTGF-backed Bomedus raises €2.5m series-B

The fresh capital will be used to launch new medical products, to foster further clinical trials and to expand the customer base internationally.

Düsseldorf-based NRW Bank Corporate Finance is the investment arm of the state development bank of Northrhine-Westphalia, specialised in direct and fund investments in small and medium-sized enterprises.

The unit invests in seed, startup, early, mid- and later-stage ventures, buyouts and spin-offs. It provides both private equity and venture capital financing.

Previous funding
In April 2012, High-Tech Gründerfonds (HTGF) invested an undisclosed amount in Bomedus.

Company
Established in 2012 as a spinout from University Clinic of Bonn, Bomedus develops medical devices that decrease the chronical pain of patients.

The product portfolio is based on the mechanism of an electro-therapeutic method, the so-called Small Fiber Matrix Stimulation. The technology enables patients to achieve a modulation of the pathologically altered neuronal impulses non-invasively, which has emerged through the course of chronic pain.

People
Johannes Weigl is founder and CEO of Bomedus. Thomas Raueiser is senior investment manager at NRW Bank.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Expansion
• Germany
• Venture